Selected by the European Innovation Council for BIO 2026
Cork, Ireland.
Altratech has been selected by the European Innovation Council (EIC) to join its delegation at BIO International Convention 2026, the world’s largest partnering event in biotechnology. As one of fifteen European biotech companies chosen, and one of just two from Ireland, Altratech will demonstrate its Unified platform for Multi-Modal Biomarker Detection from the EIC Pavilion in San Diego, 22-25 June 2026.
Being selected by the EIC to join their delegation at BIO International Convention strongly validates our technology and clinical progress, and reflects the growing international interest in our work. BIO is a key meeting point for the global biotech community and provides an important platform to expand our visibility, build new relationships and accelerate strategic partnerships.”
Dr. Tara Dalton, CEO, Altratech
Altratech has a strong relationship with the European Innovation Council (EIC) having been awarded €10.5m in funding from the EIC through its flagship Accelerator Programme in late 2024. Since then, Altratech have successfully completed a breakthrough pre-clinical HIV study using patient samples, conducted in partnership with San Cecilio University Hospital, Spain. This milestone follows an announcement in March where Altratech secured a development grant from the Gates Foundation to enable the delivery of digital, point-of-care, multi-analyte, molecular viral load tests capable of detecting any molecular virus.
Altratech will be present at the BIO International Convention 2026 in San Diego from June 22nd-25th. To learn more about our Company, we invite you to join us at the EIC Pavillion (Booth 2411) or to arrange a meeting email us at enquiries@altratech.com